Address
Other Office
10956 Weyburn Avenue
Suite 222
Los Angeles, CA 90024
United States
Phone
Website
Industry
Business classification
Tags
VCID: 2842
Profile
Corporate information
Also known as
Research Corporation Technologies BioVentures
Affiliate of
Registration country
Investment activity status
Active investor
Company type
The vehicle through which Research Corporation Technologies invests in start-up or early-stage companiesTeam
Current employees
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
|
Chad W Souvignier |
Funding
Funding rounds
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
Research Corporation Technologies |
+1 (520) 748-4400 |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
VasoNova Inc Leader in algorithm-based vascular navigation and measurement technology. |
United States | 1 Sep 2008 | Series B |
|
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Jan 2007 31 Dec 2001 |
Series C Initial investment. Round participant. Active |
|
|
|
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. |
United States | 1 Feb 2006 1 Oct 2004 |
Series B Initial investment. Round participant. Active |
|
|
|
Varix Medical Corp Developer of devices for chronic venous insufficiency |
United States | N/A Active |
||
|
|
APT Pharmaceuticals Inc A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. |
United States | N/A |
||
|
|
Spirogen Ltd Develops potent small molecules based on novel mechanisms and chemistry in the fight to target important cancers. |
United Kingdom | N/A |
||
|
|
Fullerene International Corp |
United States | N/A |
||
|
|
Therapeutic Human Polyclonals Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Lacoste & Romberg-Scintrex Inc |
Canada | N/A |
||
|
|
Clear Catheter Systems |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Esperance Pharmaceuticals Inc Company that develops a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. |
United States | N/A |
||
|
|
Alerion Biomedical Inc |
United States | N/A |
||
|
|
NP Photonics Inc |
United States | N/A |
||
|
|
Kerberos Proximal Solutions Inc A medical device company that has developed products for improved vascular treatments. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Jenrin Discovery Inc Developer of drugs for the treatment of inflammatory and metabolic disorders, including obesity. |
United States | N/A Initial investment. Round participant. Active |